SAREPTA THERAPEUTICS, INC. Gain (Loss) on Investments
SAREPTA THERAPEUTICS, INC. (SRPT) reported Gain (Loss) on Investments of -$448.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for the quarter ending 2026-06-30 was -$448.00K, a 101.22% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for the quarter ending 2026-03-31 was -$1.71M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for the quarter ending 2025-12-31 was $1.35M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for the quarter ending 2025-09-30 was $36.74M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for fiscal 2025 was -$15.91M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for fiscal 2024 was -$2.79M, a 282.38% decline from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. gain (loss) on investments for fiscal 2023 was $1.53M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$448.00K 10-Q · filed 2026-08-05 | -$2.16M 10-Q · filed 2026-08-05 | -$806.00K derived: sum of 3 quarters · filed 2026-08-05 | $35.93M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.71M 10-Q · filed 2026-05-06 | -$358.00K derived: sum of 2 quarters · filed 2026-05-06 | $36.38M derived: sum of 3 quarters · filed 2026-05-06 | $73.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $38.09M derived: sum of 2 quarters · filed 2026-03-02 | $74.81M derived: sum of 3 quarters · filed 2026-08-05 | -$15.91M 10-K · filed 2026-03-02 |
| 2025-09-30 | $36.74M 10-Q · filed 2025-11-06 | $73.46M derived: sum of 2 quarters · filed 2026-08-05 | -$17.27M 10-Q · filed 2025-11-06 | -$18.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $36.72M 10-Q · filed 2026-08-05 | -$54.01M 10-Q · filed 2026-08-05 | -$54.99M derived: sum of 3 quarters · filed 2026-08-05 | -$57.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$90.73M 10-Q · filed 2026-05-06 | -$91.71M derived: sum of 2 quarters · filed 2026-05-06 | -$94.59M derived: sum of 3 quarters · filed 2026-05-06 | -$94.44M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$3.86M derived: sum of 2 quarters · filed 2026-03-02 | -$3.72M derived: sum of 3 quarters · filed 2026-03-02 | -$2.79M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$2.88M 10-Q · filed 2025-11-06 | -$2.73M derived: sum of 2 quarters · filed 2025-11-06 | -$1.80M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $148.00K 10-Q · filed 2025-08-06 | $1.08M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $931.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.53M 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |